Chris Viehbacher News
Most Popular Chris Viehbacher Story
GSK CEO also-rans may get on board
Last week, the buzz about GlaxoSmithKline's CEO-presumptive Andrew Witty included worries that his Read more...
Latest Headlines
- January 27, 2010
- December 23, 2009
- December 10, 2009
- November 23, 2009
- November 2, 2009
- October 30, 2009
- September 30, 2009
- June 25, 2009
- June 19, 2009
- June 18, 2009
- February 12, 2009
- February 11, 2009
- December 4, 2008
- December 1, 2008
- October 7, 2008
- September 10, 2008
- September 9, 2008
- September 8, 2008
- May 22, 2008
- May 1, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
